References
- BarnesPJChronic obstructive pulmonary diseaseN Engl J Med200034326928010911010
- GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax20045957458015223864
- ScholsAMBuurmanWAStaal van den BrekelAJDentenerMAWoutersEFEvidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary diseaseThorax1996518198248795671
- SinDDManSFWhy are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary diseaseCirculation20031071514151912654609
- PepysMBHirschfieldGMC-reactive protein: a critical updateJ Clin Invest20031111805181212813013
- BroekhuizenRWoutersEFCreutzbergECScholsAMRaised CRP levels mark metabolic and functional impairment in advanced COPDThorax200661172216055618
- de TorresJPCordoba-LanusELopez-AguilarCC-reactive protein levels and clinically important predictive outcomes in stable COPD patientsEur Respir J20062790290716455829
- El-DeekSEMakhloufHASaleemTHMandourMAMohamedNASurfactant protein D, soluble intercellular adhesion molecule-1 and high-sensitivity C-reactive protein as biomarkers of chronic obstructive pulmonary diseaseMed Princ Pract20132246947423860258
- FirouzjahiAMonadiMKarimpoorFSerum C-reactive protein level and distribution in chronic obstructive pulmonary disease versus healthy controls: a case-control study from IranInflammation2013361122112823624662
- KaradagFKirdarSKarulABCeylanEThe value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary diseaseEur J Intern Med20081910410818249305
- Pinto-PlataVMMullerovaHTosoJFC-reactive protein in patients with COPD, control smokers and non-smokersThorax200661232816143583
- Torres-RamosYDGarcia-GuillenMLOlivares-CorichiIMHicksJJCorrelation of plasma protein carbonyls and C-reactive protein with GOLD stage progression in COPD patientsOpen Respir Med J20093616619461898
- ShameemMBhargavaRAhmadZSaadTFatimaNMalikAAssociation between serum C-reactive protein levels and other important predictive markers of outcome in COPDActa Med Iran201149182021425065
- CorsonelloAPedoneCBattagliaSPaglinoGBelliaVIncalziRAC-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD)Arch Gerontol Geriatr20115319019521074870
- VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med201318734736522878278
- CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med20043501005101214999112
- MacIntyreNCrapoROViegiGStandardisation of the single-breath determination of carbon monoxide uptake in the lungEur Respir J20052672073516204605
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J20052631933816055882
- WangerJClausenJLCoatesAStandardisation of the measurement of lung volumesEur Respir J20052651152216135736
- CrapoROMorrisAHGardnerRMReference spirometric values using techniques and equipment that meet ATS recommendationsAm Rev Respir Dis19811236596647271065
- CrapoROMorrisAHStandardized single breath normal values for carbon monoxide diffusing capacityAm Rev Respir Dis19811231851897235357
- CrapoROMorrisAHClaytonPDNixonCRLung volumes in healthy nonsmoking adultsBull Eur Physiopathol Respir1982184194257074238
- DahlMVestboJLangePBojesenSETybjaerg-HansenANordestgaardBGC-reactive protein as a predictor of prognosis in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200717525025517053205
- DahlMVestboJZachoJLangePTybjaerg-HansenANordestgaardBGC reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approachThorax20116619720421059738
- ZachoJTybjaerg-HansenAJensenJSGrandePSillesenHNordestgaardBGGenetically elevated C-reactive protein and ischemic vascular diseaseN Engl J Med20083591897190818971492
- BrownerWSNewmanTBHulleySBEstimating sample size and power: applications and examplesHulleySBCummingsSRBrownerWSGradyDGNewmanTBDesigning Clinical Research3rd edPhiladelphiaLippincott Williams & Wilkins20076594
- WacholderSSilvermanDTMcLaughlinJKMandelJSSelection of controls in case-control studies. III. Design optionsAm J Epidemiol1992135104210501595690
- ZhangYBunjhooHXiongWXuYYangDAssociation between C-reactive protein concentration and chronic obstructive pulmonary disease: a systematic review and meta-analysisJ Int Med Res2012401629163523206444
- AgustiASorianoJBCOPD as a systemic diseaseCOPD2008513313818415812
- KaptogeSDiAELoweGC-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisLancet201037513214020031199
- HershCPMillerDTKwiatkowskiDJSilvermanEKGenetic determinants of C-reactive protein in COPDEur Respir J2006281156116216971405
- van DurmeYMVerhammeKMAarnoudseAJC-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200917937538219096002
- MacNeeWAging, inflammation, and emphysemaAm J Respir Crit Care Med20111841327132922174110
- TuderRMKernJAMillerYESenescence in chronic obstructive pulmonary diseaseProc Am Thorac Soc20129626322550244
- ClappBRHingoraniADKharbandaRKInflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stressCardiovasc Res20046417217815364625
- VisserMBouterLMMcQuillanGMWenerMHHarrisTBElevated C-reactive protein levels in overweight and obese adultsJAMA19992822131213510591334
- DaneshJWheelerJGHirschfieldGMC-reactive protein and other circulating markers of inflammation in the prediction of coronary heart diseaseN Engl J Med20043501387139715070788
- MelbyeHHalvorsenDSHartzIBronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly. The Tromso Study 2001Respir Med20071012541254917825547
- BreyerMKSpruitMACelisAPRuttenEPJanssenPPWoutersEFHighly elevated C-reactive protein levels in obese patients with COPD: a fat chance?Clin Nutr20092864264719540024
- WoloshinSSchwartzLMDistribution of C-reactive protein values in the United StatesN Engl J Med20053521611161315829550
- HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med20043502645265315215480
- TamakoshiKYatsuyaHKondoTLong-term body weight variability is associated with elevated C-reactive protein independent of current body mass index among Japanese menInt J Obes Relat Metab Disord2003271059106512917711
- GanWQManSFSinDDThe interactions between cigarette smoking and reduced lung function on systemic inflammationChest200512755856415705996
- FrohlichMSundMLowelHImhofAHoffmeisterAKoenigWIndependent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95)Eur Heart J2003241365137212871694
- GompertzSBayleyDLHillSLStockleyRARelationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPDThorax200156364111120902
- TonstadSCowanJLC-reactive protein as a predictor of disease in smokers and former smokers: a reviewInt J Clin Pract2009631634164119732183